KAVIKRISHNA LABORATORY
Scientific and Industrial Research Organization (SIRO) Certified
- Das B*, Pal Bidisha, Bhuyan R, Li H, Sarma A, Gayan S, Talkudar J, Sandhya S, Bhuyan S, Gogoi G, Gouw AM, Baishya D, Gotlib JR, Kataki AC, Felsher DW, MYC regulates the HIF-2alpha stemness pathway via Nanog and Sox2 to maintain self-renewal in cancer stem cells versus non-stem cancer cells, Cancer Research (2019)
- Stashenko P, Yost S, Choi Y, Danciu T, Chen T, Yoganathan S, Kressirer C, Ruiz-Tourrelia M, Das B, Frias-Lopez J, The oral mouse microbiome promotes tumorigenesis in oral squamous cell carcinoma, mSystems (2019)
- Bayat-Mokhtari R, Baluch N, Morgatskaya E, Kumar S, Sparaneo A, Muscarella LA, Zhao S, Cheng HL, Das B, Yeger H, Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane, BMC Cancer (2019)
- Garhain J, Bhuyan S, Kalita D, Pulu I, Das B*, Bhatnagar R, Preclinical and clinical evidences of the Mycobacterium tuberculosis persistence in the hypoxic niche of bone marrow mesenchymal stem cells after therapy, Am J Pathol (2015)
- Beamer G, Major S, Das B, Campos-Neto A, Bone marrow mesenchymal stem cells provide an antibiotic-protective niche for persistent viable Mycobacterium tuberculosis that survive antibiotic treatment, Am J Pathol (2014)
- Das B*, Kashino SS, Pulu I, Kalita D, Swami V, Yeger H, Felsher DW, Campos-Neto A, CD271+ bone marrow mesenchymal stem cells provide a protective niche for dormant Mycobacterium Tuberculosis, Science Translational Medicine (2013)
- Das B*, Bayat-Mokhtari R, Tsui M, Lotfi S, Tsuchida R, Felsher DW, Herman Yeger, HIF-2alpha suppresses p53 to enhance the stemness and regenerative potential of human embryonic stem cells, Stem Cells (2012)
- Lee C G, Das B, Lin L T, Grimes C, Zhang X, Lavezzi T, Huang L, Cole J, Yau L, Li L, A rare fraction of drug resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumorigenic potential, Br J Haematol. (2012)
- Das B*, Tsuchida R, Koren G, Malkin D, Baruchel S, Yeger H, Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction, Stem Cells (2008)
- Tsuchida R, Das B*, Yeger H, Koren G, Shibuya M, Thorner PS, Baruchel S, Malkin D, Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling, Oncogene. (2008)
- Das B, Antoon R, Tsuchida R, Lotfi S, Morozova O, Farhat W, Malkin D, Koren G, Yeger H, Baruchel S, Squalene selectively protects mouse bone marrow progenitor against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth, Neoplasia (2008)
- Das B, Yeger H,Tsuchida R, Torkin R, Gee MF, Thorner PS, Shibuya M, Malkin D, Baruchel S, A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activate protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma, Cancer Res. (2005)
- Das B, Yeger H, Freedman M, Koren G, Baruchel S, In vitro cytoprotective activity of squalene in a bone marrow versus neuroblastoma model: its implication in cancer chemotherapy, Eur J Cancer. (2003)